Thrombolytic therapy for cerebral infarction.

about

Tissue plasminogen activator induced delayed edema in experimental porcine intracranial hemorrhage: reduction with plasminogen activator inhibitor-1 administration.Applications of thrombolytic therapy.

P2860

Q41962747-E5B0E04D-259A-442D-B665-6C75C4367AE7 Q48383360-5FFEC8FF-6E12-41DC-A83B-ACA0DF5C9124

P2860

Thrombolytic therapy for cerebral infarction.

Item

http://www.wikidata.org/entity/Q41165964

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Thrombolytic therapy for cerebral infarction.

@en

type

Item

label

Thrombolytic therapy for cerebral infarction.

@en

prefLabel

Thrombolytic therapy for cerebral infarction.

@en

P1476

Thrombolytic therapy for cerebral infarction.

@en

P2093

Broderick J

http://www.w3.org/2001/XMLSchema#string

Brott T

http://www.w3.org/2001/XMLSchema#string

Kothari R

http://www.w3.org/2001/XMLSchema#string

Pancioli A

http://www.w3.org/2001/XMLSchema#string

P2860

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset.

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group.

Interobserver agreement for the assessment of handicap in stroke patients.

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.

A critical appraisal of stroke evaluation and rating scales.

Early treatment for acute ischemic stroke.

Tissue plasminogen activator.

Coronary thrombolysis with Desmodus salivary plasminogen activator in dogs. Fast and persistent recanalization by intravenous bolus administration.

Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)

Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke.

P304

881-892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1553-2712.1996.TB03537.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1996-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227932773

http://www.w3.org/2001/XMLSchema#string

P698

8870763

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction

thrombolysis

Thrombolytic therapy for cerebral infarction.

about

P2860

P2860

Thrombolytic therapy for cerebral infarction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921